Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

Expired Cardiac Devices May Do Global Good, but Safety Unknown

News Features

Expired Cardiac Devices May Do Global Good, but Safety Unknown

Yael L. Maxwell

August 26, 2021

Toppling Silos, Testing Tech, and Trimming Egos: How COVID-19 May Remake Medicine

News Features

Toppling Silos, Testing Tech, and Trimming Egos: How COVID-19 May Remake Medicine

December 10, 2020

News Features

Playing With Heart: Returning Kids Safely to Sport in the COVID-19 Era

November 02, 2020

Walloped by COVID-19, US Cardiology Practices Brace for Slow Recovery

News Features

Walloped by COVID-19, US Cardiology Practices Brace for Slow Recovery

July 29, 2020

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

Calling It Quits: Cath Lab Pioneers Grapple With When to Go and What Comes Next

News Features

Calling It Quits: Cath Lab Pioneers Grapple With When to Go and What Comes Next

February 28, 2018

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

News Features

How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts

Michael O'Riordan

May 23, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.